Literature DB >> 17928746

Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction.

Naoyuki Matsuda1, Yuichi Hattori.   

Abstract

Sepsis is the leading cause of mortality in critically ill patients. In this pathological syndrome, septic shock and sequential multiple organ failure correlate with poor outcome. The pathophysiology of sepsis with acute organ dysfunction involves a highly complex, integrated response that includes activation of number of cell types, inflammatory mediators, and the hemostatic system. Central to this process may be alterations in vascular functions. This review article provides a growing body of evidence for the potential impact of vascular dysfunction on sepsis pathophysiology with a major emphasis on the endothelium. Furthermore, the role of apoptotic signaling molecules in the mechanisms underlying endothelial cell injury and death during sepsis and its potential value as a target for sepsis therapy will be discussed, which may help in the assessment of ongoing therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928746     DOI: 10.1540/jsmr.43.117

Source DB:  PubMed          Journal:  J Smooth Muscle Res        ISSN: 0916-8737


  40 in total

1.  Redox signaling and splicing dependent change in myosin phosphatase underlie early versus late changes in NO vasodilator reserve in a mouse LPS model of sepsis.

Authors:  John J Reho; Xiaoxu Zheng; Laureano D Asico; Steven A Fisher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-27       Impact factor: 4.733

2.  Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients.

Authors:  Caroline Guignant; Nicolas Voirin; Fabienne Venet; Françoise Poitevin; Christophe Malcus; Julien Bohé; Alain Lepape; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2009-08-07       Impact factor: 17.440

3.  Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammation.

Authors:  Kristopher C Dozier; Elizabeth L Cureton; Rita O Kwan; Brian Curran; Javid Sadjadi; Gregory P Victorino
Journal:  Peptides       Date:  2009-06-26       Impact factor: 3.750

4.  Deletion of the adenosine A2A receptor increases the survival rate in a mice model of polymicrobial sepsis.

Authors:  Miguel Meriño; Sebastián San Martín; Pedro Sandaña; Kurt Herlitz; Claudio Aguayo; Alejandro Godoy; Pablo Torres-Vergara; Marcelo Gonzalez; Felipe Troncoso; Jesenia Acurio; Carlos Escudero
Journal:  Purinergic Signal       Date:  2020-08-17       Impact factor: 3.765

5.  Endotoxin-induced endothelial fibrosis is dependent on expression of transforming growth factors β1 and β2.

Authors:  César Echeverría; Ignacio Montorfano; Pablo Tapia; Claudia Riedel; Claudio Cabello-Verrugio; Felipe Simon
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

6.  Investigation of novel LPS-induced differentially expressed long non-coding RNAs in endothelial cells.

Authors:  Krishna K Singh; Pratiek N Matkar; Shoaib Muhammad; Adrian Quan; Vijay Gupta; Hwee Teoh; Mohammed Al-Omran; Subodh Verma
Journal:  Mol Cell Biochem       Date:  2016-08-26       Impact factor: 3.396

7.  Protective effect of carbon monoxide pre-conditioning on LPS-induced endothelial cell stress.

Authors:  Chiara Bernardini; Augusta Zannoni; Maria Laura Bacci; Monica Forni
Journal:  Cell Stress Chaperones       Date:  2009-08-20       Impact factor: 3.667

8.  Peptide Bbeta(15-42) preserves endothelial barrier function in shock.

Authors:  Marion Gröger; Waltraud Pasteiner; George Ignatyev; Ulrich Matt; Sylvia Knapp; Alena Atrasheuskaya; Eugenij Bukin; Peter Friedl; Daniela Zinkl; Renate Hofer-Warbinek; Kai Zacharowski; Peter Petzelbauer; Sonja Reingruber
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

Review 9.  Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

Authors:  Nina A Mikirova; James A Jackson; Ron Hunninghake; Julian Kenyon; Kyle W H Chan; Cathy A Swindlehurst; Boris Minev; Amit N Patel; Michael P Murphy; Leonard Smith; Doru T Alexandrescu; Thomas E Ichim; Neil H Riordan
Journal:  J Transl Med       Date:  2009-12-15       Impact factor: 5.531

10.  VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis.

Authors:  Peter Weber; Ping Wang; Stephane Maddens; Paul Sh Wang; Rongqian Wu; Michael Miksa; Weifeng Dong; Michael Mortimore; Julian M C Golec; Peter Charlton
Journal:  Crit Care       Date:  2009-09-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.